Medicare Expands MRI Coverage for Pacemaker Patients
Patients with implanted pacemakers may now be covered under Medicare to receive medically necessary magnetic resonance imaging (MRI). The Centers for Medicare & Medicaid Services (CMS) posted on July 8 a final decision memo regarding the new coverage policy.
CMS announced on April 25 in a proposed decision memo that there is sufficient evidence to conclude MRI improves health outcomes for Medicare beneficiaries with implanted permanent pacemakers. The public comment period ended May 25, by which time CMS had received a total of nine comments.
The national coverage determination (NCD) for MRI (220.2) expands coverage of MRI to patients with implanted pacemakers that are approved for such use by the Food and Drug Administration (FDA). The only such FDA-approved pacemaker to date is the Medtronic RevoMRI SureScan Pacing System.
The FDA label specifies that a health professional who has completed cardiology SureScan training must be present during the programming of the SureScan, and a health professional who has completed radiology SureScan training must be present during the MRI scan. In addition, the device is MR-conditional, meaning that certain criteria must be met for patients to get an MRI.
Refer to the final decision memo for complete details regarding this coverage update.